DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qbccgj/stroke_pipeline) has announced the addition of the "Stroke - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for Stroke and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Stroke Overview
- Therapeutics Development
- Pipeline Products for Stroke - Overview
- Pipeline Products for Stroke - Comparative Analysis
- Stroke - Therapeutics under Development by Companies
- Stroke - Therapeutics under Investigation by Universities/Institutes
- Stroke - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Stroke - Products under Development by Companies
- Stroke - Products under Investigation by Universities/Institutes
- Stroke - Companies Involved in Therapeutics Development
Companies Mentioned Include:
- AB Science SA
- Acorda Therapeutics, Inc.
- Acticor Biotech
- Biogen, Inc.
- BioTime, Inc.
- Cardax Pharmaceuticals, Inc.
- Cellular Biomedicine Group, Inc.
- CHA Bio & Diostech Co., Ltd.
- CoDa Therapeutics, Inc.
- D-Pharm Ltd.
- Daiichi Sankyo Company, Limited
- DiaMedica Inc.
- Digna Biotech, S.L.
- NoNO, Inc.
- Omeros Corporation
- Panacea Pharmaceuticals, Inc.
- PharmatrophiX, Inc.
- Pharmicell Co., Ltd.
- Phoenix Biotechnology, Inc.
- Phylogica Limited
- PhytoHealth Corporation
- Pozen, Inc.
- Primary Peptides, Inc.
-
(Others)
For more information visit http://www.researchandmarkets.com/research/qbccgj/stroke_pipeline
